Why CVS Stock Trounced the Market Today
It's expanding its scope of services for GLP-1 obesity medications.
Overview
CVS Health (NYSE: CVS) is pushing harder into a hot segment of the pharmacy market, and on Monday investors rewarded the company for the effort. The pharmacy retailer's stock rose 3% on the news, contrasting very favorably with the slight (0.2%) decline of the bellwether S&P 500 index.
That morning, before market open, CVS announced it is expanding support for GLP-1 weight-loss medications across its many U.S. pharmacies and MinuteClinics.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.